Literature DB >> 35699815

ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC.

Patrick B Schwartz1, Daniel E Abbott2.   

Abstract

The substantial cost of care for patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy can be augmented by changes in practice patterns. This report discusses the recent publication of the authors' group and their thoughts on cost-conscious cancer care.
© 2022. Society of Surgical Oncology.

Entities:  

Mesh：

Year:  2022        PMID： 35699815     DOI： 10.1245/s10434-022-12015-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


  5 in total

1.  Effect of Hospital Safety-Net Burden on Cost and Outcomes After Surgery.

Authors:  Richard S Hoehn; Koffi Wima; Matthew A Vestal; Drew J Weilage; Dennis J Hanseman; Daniel E Abbott; Shimul A Shah
Journal:  JAMA Surg       Date:  2016-02       Impact factor: 14.766

2.  ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC.

Authors:  Patrick B Schwartz; Daniel E Abbott
Journal:  Ann Surg Oncol       Date:  2022-06-14       Impact factor: 4.339

3.  Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement.

Authors:  Harveshp D Mogal; Edward A Levine; Nora F Fino; Chukwuemeka Obiora; Perry Shen; John H Stewart; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2015-11-16       Impact factor: 5.344

4.  What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?

Authors:  Patrick B Schwartz; Christopher C Stahl; Kara A Vande Walle; Courtney J Pokrzywa; Linda M Cherney Stafford; Taylor Aiken; James Barrett; Alexandra W Acher; Glen Leverson; Sean Ronnekleiv-Kelly; Sharon M Weber; Daniel E Abbott
Journal:  Ann Surg Oncol       Date:  2020-05-15       Impact factor: 5.344

5.  The impact of profitability of hospital admissions on mortality.

Authors:  Richard C Lindrooth; R Tamara Konetzka; Amol S Navathe; Jingsan Zhu; Wei Chen; Kevin Volpp
Journal:  Health Serv Res       Date:  2013-01-24       Impact factor: 3.734
  5 in total
  1 in total

1.  ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC.

Authors:  Patrick B Schwartz; Daniel E Abbott
Journal:  Ann Surg Oncol       Date:  2022-06-14       Impact factor: 4.339
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.